Literature DB >> 14555911

Defining complex contributions of NOD2/CARD15 gene mutations, age at onset, and tobacco use on Crohn's disease phenotypes.

Steven R Brant1, Michael F Picco, Jean-Paul Achkar, Theodore M Bayless, Sunanda V Kane, Aaron Brzezinski, Franklin J Nouvet, Denise Bonen, Amir Karban, Themistocles Dassopoulos, Reda Karaliukas, Terri H Beaty, Stephen B Hanauer, Richard H Duerr, Judy H Cho.   

Abstract

BACKGROUND: Multiple factors, particularly IBD family history, tobacco use, age at diagnosis and recently, NOD2 mutant genotypes may influence Crohn's disease (CD) heterogeneity.
METHODS: We performed a multicenter retrospective record analysis of 275 unrelated patients with CD. Age at diagnosis, IBD family history, Jewish ethnicity, tobacco use at diagnosis, surgical history, disease site and clinical behavior were correlated with genotypes for NOD2 mutations, and all risk factors were assessed for independent influence on outcomes of disease site, behavior and surgery free survival.
RESULTS: Risk of ileal disease was increased for CD patients with two NOD2 mutations (Odds Ratio, O.R. 10.1), a smoking history (O.R. 2.25 per pack per day at diagnosis) or a younger age at diagnosis (O.R. 0.97 per each increased year). Presence of ileal disease (O.R. 4.8) and carrying one or two NOD2 mutations (O.R. 1.9 and 3.5, respectively) were independent risk factors for stricturing or non-perianal fistulizing behavior. Ileal disease, youthful onset and smoking at diagnosis (but not NOD2 mutations) were risk factors for early surgery.
CONCLUSIONS: Carrying two NOD2 mutations predicts youthful onset, ileal disease involvement, and development of stricturing or non-perianal fistulizing complications. Smoking and early onset independently influence ileal site and time to surgery.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14555911     DOI: 10.1097/00054725-200309000-00001

Source DB:  PubMed          Journal:  Inflamm Bowel Dis        ISSN: 1078-0998            Impact factor:   5.325


  59 in total

Review 1.  Inflammatory bowel disease.

Authors:  R M Beattie; N M Croft; J M Fell; N A Afzal; R B Heuschkel
Journal:  Arch Dis Child       Date:  2006-05       Impact factor: 3.791

2.  Smoking and inflammatory bowel diseases: what in smoking alters the course?

Authors:  A M El-Tawil
Journal:  Int J Colorectal Dis       Date:  2010-03-24       Impact factor: 2.571

3.  Tailoring the treatment to the individual in Crohn's disease.

Authors:  Edouard Louis; Jacques Belaiche; Catherine Reenaers
Journal:  Therap Adv Gastroenterol       Date:  2009-07       Impact factor: 4.409

Review 4.  Genotypes and phenotypes in Crohn's disease: do they help in clinical management?

Authors:  C Gasche; P Grundtner
Journal:  Gut       Date:  2005-01       Impact factor: 23.059

Review 5.  Genetics of inflammatory bowel disease: current status and future directions.

Authors:  Thomas D Walters; Mark S Silverberg
Journal:  Can J Gastroenterol       Date:  2006-10       Impact factor: 3.522

Review 6.  The role of smoking in Crohn's disease as defined by clinical variables.

Authors:  Suhal S Mahid; Kyle S Minor; Patrick L Stevens; Susan Galandiuk
Journal:  Dig Dis Sci       Date:  2007-03-31       Impact factor: 3.199

7.  Testing the interaction between NOD-2 status and serological response to Mycobacterium paratuberculosis in cases of inflammatory bowel disease.

Authors:  Charles N Bernstein; Ming-Hsi Wang; Michael Sargent; Steven R Brant; Michael T Collins
Journal:  J Clin Microbiol       Date:  2007-01-24       Impact factor: 5.948

Review 8.  Effect of smoking on inflammatory bowel disease: Is it disease or organ specific?

Authors:  A Karban; R Eliakim
Journal:  World J Gastroenterol       Date:  2007-04-21       Impact factor: 5.742

9.  Role of Salmonella enterica exposure in Chilean Crohn's disease patients.

Authors:  Manuel Alvarez-Lobos; Daniela P Pizarro; Christian E Palavecino; Abner Espinoza; Valentina P Sebastián; Juan C Alvarado; Patricio Ibañez; Carlos Quintana; Orlando Díaz; Alexis M Kalergis; Susan M Bueno
Journal:  World J Gastroenterol       Date:  2013-09-21       Impact factor: 5.742

10.  Gastroduodenal Crohn's disease is associated with NOD2/CARD15 gene polymorphisms, particularly L1007P homozygosity.

Authors:  Houssam E Mardini; Kalvin J Gregory; Munira Nasser; Lisbeth Selby; Razvan Arsenescu; Trevor A Winter; Willem J S de Villiers
Journal:  Dig Dis Sci       Date:  2005-12       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.